Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

PaperCitations, authors & open-access status

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 246 citations, 2021 year and green oa status.

246
Citations
2021
Year
green
OA Status

Related on ScholarIQ

Domenico Santoro
Author
Riccardo Magistroni
Author
Loreto Gesualdo
Author
Journal of the American Society of Nephrology
Journal
Renal Diseases and Glomerulopathies
Topic
Renal Diseases and Glomerulopathies
Topic
470M+ articles · free account